SIGA Technologies, Inc. (NASDAQ:SIGA)
CAPS Rating:
A bio-defense company engaged in the discovery, development and commercialization of products for use in defense against biological warfare agents such as Smallpox and Arenaviruses.
RSS Headlines
Fool UK
Recs
They are the only company with a drug that actually meets the RFP. Siga's drug works...there are no other options.I thought negotiating a deal wasn't "doing a deal". Nothing was signed? How can they be forced to share 50% of the upside for a 3M loan which they paid back in full with interest.
SIGA lost. Get over it.